Liver transplantation and multivisceral transplantation in the management of patients with advanced neuroendocrine tumours

Table 1 Results from liver transplantation in selected registry reports, multicentre series and recent single centre series

Ref.	Year	Study type/setting	Total patients	Overall survival (%)							Disease-free survival (%)
					1 yr	2 yr	3 yr	4 yr	5 yr	10 yr	1 yr	2 yr	3 yr	4 yr	5 yr	10 yr
Nobel et al[58]	2015	Registry (UNOS)	120		87		69		63
Le Treut et al[38]	2013	Registry (ELTR)	213 (6 MVT)	Overall	81	73	65	55	52		65	49	40	33	30
				ELTR score 0-1					79						57
				ELTR score 2-3					38						19
Nguyen et al[40]	2011	Registry (UNOS)	184	Overall	79.5		61.4		49.2
				Post-MELD	84.7		65		57.8
Gedaly et al[37]	2011	Registry (UNOS)	150 (13 MVT)		80		64		48		771		501		321
Sher et al[51]	2015	Multicentre series (United States)	85		83		60		52
Mazzaferro et al[9]	2016	Single centre series (Italy)	42						97.2	88.8					86.9	86.9
Bonaccorsi-Riani et al[59]	2010	Single centre series (Belgium)	9		88		77		33		67		33		11
Olausson et al[50]	2007	Single centre series (Sweden)	15 (5 MVT)						90				70		20
Van Vilsteren et al[60]	2006	Single centre series (United States)	19		88						80
Frilling et al[61]	2006	Single centre series (Germany)	15 (1 MVT)		78.3				67.2		69.4				48.3

Calculated from 83 patients. UNOS: United Network for Organ Sharing (United States); ELTR: European Liver Transplant Registry; MELD: Modified end-stage liver disease score; MVT: Multivisceral transplantation.